Newstral
Athersys
- Global Tissue Engineering Market Demad, Growth | Acelity, Integra Lifesciences, C. R. Bard, Zimmer Biometcolemannews.com
- Remote Work Employee Win!jdsupra.com
- GRegenerative Drugs Market – Outlook and Forecast 2022-2028galleonnews.com
- GRegenerative Drugs Market – Global Outlook and Forecast 2022-2028galleonnews.com
- Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin SoonForbes
- MAthersys's stock shoots up after FDA OKs study for COVID-19-induced respiratory distress treatmentmarketwatch.com
- Cleveland biotech company making headway on possible COVID-19 treatmentFox News
- Cell therapy touted as possible coronavirus treatment by Cleveland biotech companyFox News
- AthersysForbes
- HFDA designation 'really big deal' for Athersyshome.crainscleveland.com
- HFDA to Athersys: Design of large stem cell trial looks goodhome.crainscleveland.com
- HAthersys cell therapy beats placebo, impresses investorshome.crainscleveland.com
- Spinal Cord patient reacts to stem cell breakthroughWKYC Channel 3 News
- Local company invents stem cell breakthroughWKYC Channel 3 News
- HAthersys strikes licensing deal with new Japanese partnerhome.crainscleveland.com
- HAthersys, Chugai Pharmaceutical end partnership on stroke cell therapyhome.crainscleveland.com
- HAthersys' stroke clinical trial yields disappointing resultshome.crainscleveland.com
- HAthersys to announce data from ongoing stroke clinical trial in Aprilhome.crainscleveland.com
- HAthersys teams with Chugai Pharmaceutical to develop cell therapy in Japanhome.crainscleveland.com
- CAthersys to start new clinical trialcrainscleveland.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.